Fenbendazole is a popular dog wormer ingredient that has been shown to have some cancer-fighting properties. It inhibits glucose uptake and appears to disrupt the proper formation of microtubules in cancer cells. This may cause the cells to die. The drug also activates the WT p53 tumor suppressor, which is known to promote cell death.
In addition, fenbendazole has been shown to block the ability of certain tumors to grow blood vessels. It can also prevent tumors from stealing nutrients and oxygen from surrounding healthy tissue. It also has the potential to help chemotherapy drugs work more effectively.
It has been claimed that fenbendazole can kill cancer cells, including the most resistant ones, by binding to the microtubules and inhibiting their growth. This mechanism of action is similar to that of some other anticancer drugs, such as mitomycin C and vinblastine. In one study, fenbendazole was found to induce G2/M arrest and apoptosis in 5-FU-sensitive and -resistant colorectal cancer cells. The cells with wild-type p53 showed higher sensitivity to the drug than those with mutant p53.
Another way fenbendazole may kill cancer is by inducing ferroptosis. In this process, cancer cells release a series of toxic proteins into the surrounding tissue that can kill the cell. This effect was found to be mediated by mitochondrial depolarization, which leads to an increase in the activity of caspase-3 and poly (ADP-ribose) polymerase.
Whether or not fenbendazole actually kills cancer cells hasn’t been tested in human trials. It does appear to be effective in mice, though, where it has been shown to reduce the size of tumors and improve the ability of chemotherapy drugs to penetrate cancerous tissue. It is important to note that many people who have used fenbendazole in their fight against cancer are taking it alongside other conventional treatments, such as chemotherapy and radiation. As such, it’s impossible to attribute any success stories to the use of fenbendazole alone.
Joe Tippens, for example, was diagnosed with stage 4 brain cancer and given three months to live. He decided to try a protocol that included fenbendazole and other ingredients, and he claims his cancer is now in remission.
A lot of research needs to be done before fenbendazole can be considered a viable treatment option for humans. For now, it is best to consult with a medical professional before starting this or any other alternative treatment. It is also important to discuss the risks and benefits of the medication with your doctor. fenbendazole for cancer